Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Long-Term Debt Repayments (2019 - 2021)

GeoVax Labs' Long-Term Debt Repayments history spans 3 years, with the latest figure at $24801.0 for Q2 2021.

  • Quarterly results put Long-Term Debt Repayments at $24801.0 for Q2 2021, up 740.14% from a year ago — trailing twelve months through Mar 2022 was $24801.0 (up 106.18% YoY), and the annual figure for FY2024 was $150000.0, changed.
  • Long-Term Debt Repayments for Q2 2021 was $24801.0 at GeoVax Labs, up from $3063.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $24801.0 in Q2 2021 to a low of $1924.0 in Q4 2019.
  • The 3-year median for Long-Term Debt Repayments is $3007.0 (2020), against an average of $5000.1.
  • The sharpest move saw Long-Term Debt Repayments decreased 5.57% in 2020, then soared 740.14% in 2021.
  • Year by year, Long-Term Debt Repayments stood at $1924.0 in 2019, then soared by 57.28% to $3026.0 in 2020, then surged by 719.6% to $24801.0 in 2021.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $24801.0, $3063.0, and $3026.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.